Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus dexmedetomidine for controlled hypotension during adult nasal surgery
PACTR202001644289774Recruiting
- Sponsor
- Amir Abouzkry
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remifentanil and dexmedetomidine in ear (not a disease), sponsored by Amir Abouzkry. Primary endpoint: Clarity and dryness of the surgical field. Started Jan 2020; status: recruiting.
02
Drugs
remifentanildexmedetomidine
03
Conditions
ear (not a disease)
Beyond the preview
Go deeper on PACTR202001644289774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001644289774.